Lack or loss of sexual desire. Orgasmic disorder. Dyspareunia
Conditions
Interventions
This is a randomized clinical trial, whose n=240 women with sexual dysfunction will undergo stratified randomization into two groups of 120 women: experimental and control groups. Experimental group:
Sponsors
Universidade Federal do Maranhão
Universidade de São Paulo
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: sexually active women; 18 to 45 years old; with sexual dysfunction according to the FSFI instrument; score less than or equal 26
Exclusion criteria
Exclusion criteria: women under the age of 18 who has any of the following morbidities;Diabetes; arterial hypertension; thyroid diseases such as neuropathies; depression; hyperprolactinemia; hypoandrogenism; vaginismus; or use of benzodiazepines; antidepressants; antidopaminergic antipsychotics; antiandrogens; beta adrenergic blockers; centrally acting antihypertensives; histamine H2 blockers ; or that report the presence of a third persons at the place of sexual intercourse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome will be the proportion comparasion of participants who present FSFI scores above 26, assessed 60 days after the 1st intervention, in both groups, Experimental Group and Control Group, in two moments, pre (first contact) and post-intervention (60 days) through the FSFI. | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion comparasion of participants with a Dyadic Adjustment Scale (EAD) score >101 points in both groups, Experimental Group and Control Group, in two moments, pre (first contact) and post-intervention (60 days).;Comparison of mean quality of life according to the WHOQOL-26 questionnaire in both groups, Experimental Group and Control Group, in two moments, pre (first contact) and post-intervention (60 days). | — |
Countries
Brazil
Contacts
Public ContactPedro Lemos da Silva
Universidade de São Paulo
Outcome results
None listed